FR901469, a novel antifungal antibiotic from an unidentified fungus No. 11243. III. Structure determination. 2001

A Fujie, and H Muramatsu, and S Yoshimura, and M Hashimoto, and N Shigematsu, and S Takase
Exploratory Research Laboratories, Fujisawa Pharmaceutical Co., Ltd., Tsukuba, Ibaraki, Japan.

A novel antifungal antibiotic, FR901469, was isolated from an unidentified fungus No. 11243. It is a water-soluble 40-membered macrocyclic lipopeptidolactone, consisting of D-Ala, L-Tyr, L-Val, trans-4OH-L-Pro, trans-3OH-L-Pro, threo-3OH-L-Gln, Gly, L-Orn, L-Thr, three residues of D-alloThr and a (3R)-hydroxypalmitic acid. Its structure, including absolute configurations, was unequivocally determined as 1 based on chemical and spectroscopic evidence.

UI MeSH Term Description Entries
D008968 Molecular Conformation The characteristic three-dimensional shape of a molecule. Molecular Configuration,3D Molecular Structure,Configuration, Molecular,Molecular Structure, Three Dimensional,Three Dimensional Molecular Structure,3D Molecular Structures,Configurations, Molecular,Conformation, Molecular,Conformations, Molecular,Molecular Configurations,Molecular Conformations,Molecular Structure, 3D,Molecular Structures, 3D,Structure, 3D Molecular,Structures, 3D Molecular
D009682 Magnetic Resonance Spectroscopy Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D010456 Peptides, Cyclic Peptides whose amino acid residues are linked together forming a circular chain. Some of them are ANTI-INFECTIVE AGENTS; some are biosynthesized non-ribosomally (PEPTIDE BIOSYNTHESIS, NON-RIBOSOMAL). Circular Peptide,Cyclic Peptide,Cyclic Peptides,Cyclopeptide,Orbitide,Circular Peptides,Cyclopeptides,Orbitides,Peptide, Circular,Peptide, Cyclic,Peptides, Circular
D005658 Fungi A kingdom of eukaryotic, heterotrophic organisms that live parasitically as saprobes, including MUSHROOMS; YEASTS; smuts, molds, etc. They reproduce either sexually or asexually, and have life cycles that range from simple to complex. Filamentous fungi, commonly known as molds, refer to those that grow as multicellular colonies. Fungi, Filamentous,Molds,Filamentous Fungi,Filamentous Fungus,Fungus,Fungus, Filamentous,Mold
D000935 Antifungal Agents Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. Anti-Fungal Agents,Antifungal Agent,Fungicides, Therapeutic,Antibiotics, Antifungal,Therapeutic Fungicides,Agent, Antifungal,Anti Fungal Agents,Antifungal Antibiotics
D047630 Depsipeptides Compounds consisting of chains of AMINO ACIDS alternating with CARBOXYLIC ACIDS via ester and amide linkages. They are commonly cyclized. Cyclic Depsipeptide,Cyclodepsipeptide,Depsipeptide,Peptolide,Peptolides,Cryptophycins,Cyclodepsipeptides,Depsipeptides, Cyclic,Cyclic Depsipeptides,Depsipeptide, Cyclic

Related Publications

A Fujie, and H Muramatsu, and S Yoshimura, and M Hashimoto, and N Shigematsu, and S Takase
April 2015, Genome announcements,
A Fujie, and H Muramatsu, and S Yoshimura, and M Hashimoto, and N Shigematsu, and S Takase
May 2002, The Journal of antibiotics,
A Fujie, and H Muramatsu, and S Yoshimura, and M Hashimoto, and N Shigematsu, and S Takase
May 2005, Bioscience, biotechnology, and biochemistry,
A Fujie, and H Muramatsu, and S Yoshimura, and M Hashimoto, and N Shigematsu, and S Takase
March 2000, The Journal of antibiotics,
A Fujie, and H Muramatsu, and S Yoshimura, and M Hashimoto, and N Shigematsu, and S Takase
April 2003, Bioorganic & medicinal chemistry letters,
A Fujie, and H Muramatsu, and S Yoshimura, and M Hashimoto, and N Shigematsu, and S Takase
July 2017, Journal of bioscience and bioengineering,
A Fujie, and H Muramatsu, and S Yoshimura, and M Hashimoto, and N Shigematsu, and S Takase
May 2005, Bioscience, biotechnology, and biochemistry,
A Fujie, and H Muramatsu, and S Yoshimura, and M Hashimoto, and N Shigematsu, and S Takase
July 1971, Journal of the American Chemical Society,
A Fujie, and H Muramatsu, and S Yoshimura, and M Hashimoto, and N Shigematsu, and S Takase
April 1969, Journal of the American Chemical Society,
A Fujie, and H Muramatsu, and S Yoshimura, and M Hashimoto, and N Shigematsu, and S Takase
February 2003, The Journal of antibiotics,
Copied contents to your clipboard!